Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: J Mol Med (Berl). 2014 Jan 25;92(5):473–485. doi: 10.1007/s00109-014-1120-y

Figure 6. ASM activity and lysosomal cathepsin activity in CASMCs upon atherogenic stimulation.

Figure 6

(A) and (B) Summarized data show the catalytic activities for lysosomal cathepsin B and D by fluorogenic substrate assay in Smpd1+/+ and Smpd1−/− CASMCs under control or 7-Ket (10 μM; 24 hours) stimulation. * P<0.05 vs. Smpd1+/+ control; #P < 0.05 Smpd1−/− vs. Smpd1+/+ (n=4).